(美国商业资讯)-- 全球性投资者权益律师事务所Rosen Law Firm提醒投资者,一名股东代表在2024年5月9日至2025年5月8日期间购买Iovance Biotherapeutics, Inc. (NASDAQ: IOVA)证券的投资者提起了集体诉讼。Iovance是一家处于商业化阶段的生物制药公司。如需了解更多信息,请提交 表格 、向Phillip Kim律师 发送电子邮件 ,或致电...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.